Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag

BACKGROUND: Eltrombopag, a nonpeptide thrombopoietin receptor agonist (TPO-RA), has been reported to be an effective therapy for chronic immune thrombocytopenia (ITP). However, a higher incidence of arterial and venous thromboembolic events was reported after using eltrombopag. CASE PRESENTATION: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Satoh, Terumori, Saotome, Masao, Suwa, Kenichiro, Ohtani, Hayato, Nagata, Yasuyuki, Ono, Takaaki, Maekawa, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458957/
https://www.ncbi.nlm.nih.gov/pubmed/31049228
http://dx.doi.org/10.1155/2019/2756319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458957/
https://www.ncbi.nlm.nih.gov/pubmed/31049228
http://dx.doi.org/10.1155/2019/2756319

Ejemplares similares